🏥 The Hidden Cost of Plasma Donation

Editors’ Note: Our website features a healthspan-focused job board, an archive of past newsletters, a growing dictionary of terms we’ve highlighted in previous editions and more to come!

Visit us at: https://stacked-health.com/

Or copy and paste this link to others: {{rp_refer_url}}

Try Factor, America's #1 ready-to-eat meal delivery service.

Made from ingredients you recognize. Whole food. Nothing unnecessary. Let’s eat real.

Get 50% off your first Factor box + Free Breakfast for a year *1 free breakfast item per box for 1 year while subscription active.

Try Factor Now

Plasma is the liquid part of blood, about 55% of its volume. It's mostly water. What's dissolved in it matters more: albumin, which keeps fluid inside your blood vessels. Antibodies, which fight infection. Clotting factors, which stop bleeding.

None of it can be manufactured. There's no synthesis route to a human antibody pool. If you want immunoglobulin, you have to take it out of a person.

That single fact built a global industry, and the United States dominates it. We supply roughly 70% of the world's plasma. Blood products sit consistently among the top ten US exports by value, worth more in some years than coal or gold. The reason isn't that Americans are unusually generous. Paying people for plasma is legal here and banned almost everywhere else. Only a handful of other countries allow compensation, and those plus the US account for close to 90% of global supply.

Twice a week, 48 hours apart

An American can donate plasma up to 104 times a year, with a minimum of 48 hours between sessions. European guidance has historically recommended a ceiling closer to 33 donations a year, with much longer gaps between them. That's a threefold difference in extraction rate from the same biology.

Centers pay around $30 to $50 per session, with introductory offers reaching several hundred dollars in the first month. Researchers who have mapped where these centers get built find them concentrated in high-poverty zip codes. For a meaningful number of donors, plasma income isn't supplemental. It's how rent gets paid.

Which raises a question the industry has been slow to answer. What does removing 700 milliliters of protein-rich fluid twice a week do to the person doing it?

What comes out, and how long it takes to come back

A randomized trial published in late 2025 followed 120 male donors across three groups: high-frequency donation, regular-frequency donation, and a whole-blood control. The high-frequency donors finished with total serum protein 5.5 grams per liter below controls, and immunoglobulin G 2.8 grams per liter below. The drops showed up across IgG subclasses, IgM, IgA, ferritin, and hemoglobin, and got worse the more often people donated.

The detail worth sitting with is the recovery curve. Many of those markers still hadn't returned to baseline four weeks after the last donation, in a protocol less aggressive than what American rules allow. An earlier trial testing twice-weekly donation, the American maximum, found a 60% drop in ferritin and a 38% drop in IgG.

A systematic review landed somewhere careful. Very high frequency donation may push IgG below the European regulatory floor of 6 grams per liter and may cause meaningful iron depletion. But the evidence is low certainty, the studies are short, and donors start out as a self-selected healthy population. Nobody has run the twenty-year cohort. The US permits the highest donation frequency in the world and has among the thinnest evidence about what it costs the donor.

What a donation becomes

The other end of the pipe explains why the rules are written the way they are.

One year of immunoglobulin therapy for a single patient with primary immunodeficiency, a genetic condition where the body can't produce working antibodies, takes roughly 130 donations. Alpha-1 antitrypsin deficiency, where a missing protein leaves lung tissue exposed to enzymatic damage, takes about 900. Hemophilia takes more than 1,200.

Demand for immunoglobulin has grown around 8% a year for over a decade. That growth is driven less by rare disease and more by steady expansion into neurological and autoimmune indications. A single manufacturing batch pools plasma from thousands of donors on purpose. The goal is the widest possible antibody repertoire, so you average across as many immune histories as you can collect.

The same protein, going the other way

Here's where it gets strange.

Therapeutic plasma exchange removes a person's plasma and replaces it, usually with albumin solution and saline. It's been used clinically for decades, in conditions like myasthenia gravis. The longevity field picked it up recently on the theory that aging plasma accumulates inflammatory and senescence-associated signaling proteins, and that diluting them might produce a systemic benefit. It's the clinical descendant of the parabiosis experiments, where old and young mice were surgically joined and the old ones improved.

In 2025, a single-blind, placebo-controlled trial published results in adults over 50. Thirty participants were split across monthly exchange, biweekly exchange, biweekly exchange combined with intravenous immunoglobulin, and a control group. The best-performing arm was the one that put immunoglobulin back in. It reduced biological age by an average of 2.6 years across a panel of multi-omic markers, including epigenetic clocks, proteomic signatures, and immune cell composition.

The strongest signal didn't come from washing out old plasma. It came from washing out old plasma and replacing part of it with pooled antibodies harvested from other people.

So the chain runs like this. Immunoglobulin gets extracted from donors paid $50 a visit, whose own IgG measurably declines as a result. It gets pooled across thousands of immune systems. Then it gets infused into people over 50, in some cases at longevity clinics, where it appears to move biological age markers in the right direction.

How much of this to believe

The trial had thirty people, ten per arm. Effects appeared to fade over time. Epigenetic clocks are noisy instruments that often disagree with each other and haven't been validated against hard outcomes like mortality. The study was also run by a company that sells the procedure, in partnership with an academic institute. That's normal for early longevity research, and still worth keeping in mind.

The donor-side evidence has its own problems. Small trials, short follow-up, mostly men.

What survives both sets of caveats is the underlying observation. Circulating plasma protein isn't inert cargo. It's a compartment with a level. That level moves in response to what you do to it, and moving it in either direction seems to have consequences well beyond the bloodstream.

Why you should care

Almost nobody looks at this compartment, even though most people have already been handed the data. Total protein, albumin, and globulin appear on the basic metabolic panel that comes back from nearly every routine blood draw. They're among the least discussed numbers on the page, usually flagged only when they fall outside a reference range wide enough to hide a real downward trend.

If you donate plasma regularly, those numbers are worth tracking as a trend, not a single check. One value inside the range tells you very little. A slope over a year tells you a lot, and recovery takes longer than the 48-hour gap the rules allow.

If you're being sold plasma exchange as a healthspan intervention, the fair read is that something real may be happening, and the evidence isn't yet strong enough to justify what it currently costs.

One of the more promising healthspan interventions on offer today is made from a raw material collected, at the highest permitted frequency in the world, from people selling it because they need the money. That's not an argument against paid donation, which is the only reason a global supply exists at all. It's an argument that the donor side of this system deserves the same research attention the recipient side is finally starting to get.

Or copy and paste this link to others: {{rp_refer_url}}

Current Referral Count: {{rp_num_referrals}}